Deficiency of adenosine deaminase 2 skews adaptive immune repertoires toward specific sets of T- and B-cell receptors., PMID:39924119
Advances in Focal Segmental Glomerulosclerosis Treatment From the Perspective of the Newest Mechanisms of Podocyte Injury., PMID:39935575
Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay., PMID:39936124
Optimizing rWTC-MBTA Vaccine Formulations, Dosing Regimens, and Cryopreservation Techniques to Enhance Anti-Metastatic Immunotherapy., PMID:39941108
CD40 induces PIR-A+ macrophages to promote chronic allograft rejection., PMID:39954660
Spatially Resolved, Multiregion Proteomics for Prediction of Immunotherapy Outcome in Deficient Mismatch Repair Metastatic Colorectal Cancer., PMID:39969975
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer., PMID:39972124
Modified CD40L-Activated B-Cell Proliferation Model for Validating the Suppressive Activity of CD40-CD154 Pathway Inhibitors., PMID:39994946
Humanized FcεRI Expressed on Mouse Eosinophils Mediates IgE-Facilitated Eosinophil Antigen Presentation., PMID:39996772
IL-1R1 Blockade Boosts CD40 Agonist Immune Responses but Fails to Improve Efficacy or Reduce Hepatotoxicity in Pancreatic Cancer., PMID:40060615
Influence of environmental exposures on T follicular helper cell function and implications on immunity: a comparison of Bangladeshi and American children., PMID:40062864
Elevated serum CD40 as a potential biomarker for the differential diagnosis of acute thyrotoxic myopathy., PMID:40069315
Comparison of human macrophages derived from peripheral blood and bone marrow., PMID:40073092
Suppression of NF-κB and downstream XBP1 by DcR3 contributes to a decrease in antibody secretion., PMID:40073262
Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors., PMID:40074330
Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement., PMID:40090010
Two-year treatment experience with BI 655064, an antagonistic anti-CD40 antibody, in patients with active lupus nephritis: An exploratory, phase II maintenance trial., PMID:40104960
Development of a Tumor-Specific Multivalent CD40 Agonist Antibody FAPxCD40 for Cancer Therapy: Balancing Efficacy and Toxicity., PMID:40111090
Lupenone preserves T cell activity by recovery of CD40L expression and protection from cytotoxicity due to methamphetamine exposure., PMID:40111983
Facts and Hopes of CD40 Agonists in Cancer Immunotherapy., PMID:40117130
Targeted immunotherapies for Graves' thyroidal & orbital diseases., PMID:40145088
Integrative miRNA-mRNA profiling uncovers mechanisms of belimumab action in systemic lupus erythematosus., PMID:40160819
Modulating IL-21-driven B cell responses in idiopathic inflammatory myopathies via inhibition of the JAK/STAT pathway., PMID:40170058
CAR Treg synergy with anti-CD154 promotes infectious tolerance and dictates allogeneic heart transplant acceptance., PMID:40197364
Recognition of different subsets of alloreactive T cells by activation-induced markers., PMID:40204006
Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling., PMID:40217113
The immune checkpoint regulator CD40 potentiates myocardial inflammation., PMID:40217124
OMIP-113: Characterization of Cytokine Producing T Cells in Swine., PMID:40231482
LILRB2 blockade facilitates macrophage repolarization and enhances T cell-mediated antitumor immunity., PMID:40246582
CD40 promotes AML survival via non-canonical NF-κB signaling and aberrant lipid metabolism., PMID:40252467
A promising endeavor against human cytomegalovirus: Predominant epitopes-based recombinant subunit vaccine RHEcIE1/pp65/pp150., PMID:40277436
Berberine Suppression of Human IgE but Not IgG Production via Inhibition of STAT6 Binding Activity at IgE Promoter by BCL6., PMID:40277916
Aerosol Delivery of Hesperetin-Loaded Nanoparticles and Immunotherapy Increases Survival in a Murine Lung Cancer Model., PMID:40278452
Multi-epitope microsphere vaccine modified immunological efficacy against LMBV in largemouth bass (Micropterus salmoides)., PMID:40279807
Characterizing TLR4 agonist EmT4™ as an anti-Mycobacterium tuberculosis vaccine adjuvant., PMID:40285479
Extracellular Vesicle Marker Changes Associated With Disease Activity in Relapsing-Remitting Multiple Sclerosis., PMID:40300121
Identification of soluble biomarkers that associate with distinct manifestations of long COVID., PMID:40307449
The role of soluble CD40L in autoimmune diseases., PMID:40329996
Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells., PMID:40341026
Dose Selection for DuoBody®-CD40x4-1BB (GEN1042/BNT312) Using a mPBPK/RO Model Leveraging Preclinical and Clinical Data., PMID:40347227
Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis., PMID:40358149
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice., PMID:40360777
Mechanisms of tumor-associated macrophages promoting tumor immune escape., PMID:40371816
Single Treatment Boiling Histotripsy Focused Ultrasound Ablation Neither Negates nor Enhances the Activity of α-CD40 in a Pancreatic Cancer Model., PMID:40372859
Advances in Subclinical and Clinical Trials and Immunosuppressive Therapies in Xenotransplantation., PMID:40387233
Adoptively transferred macrophages for cancer immunotherapy., PMID:40413021
Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform., PMID:40417977
A novel cationic liposome-formulated toll like receptor (TLR) 7/8 agonist enhances the efficacy of a vaccine against fentanyl toxicity., PMID:40441493
Synergy and antagonism in the integration of BCR and CD40 signals that control B-cell population expansion., PMID:40473841
Mechanistic investigation of calcium phosphate mineralization potentiating the cellular immune response of foot-and-mouth disease virus-like particle vaccines., PMID:40512119
For research use only. Not for human or drug use.
